{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T05:02:34Z","timestamp":1731128554703,"version":"3.28.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,7]]},"DOI":"10.7759\/cureus.73248","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T04:16:04Z","timestamp":1731039364000},"source":"Crossref","is-referenced-by-count":0,"title":["Bullous Symmetric Drug-Related Intertriginous and Flexural Exanthem Secondary to Trimethoprim\/Sulfamethoxazole"],"prefix":"10.7759","author":[{"given":"Mishma A","family":"Farsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asena","family":"Markal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Maddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Forouzandeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Motaparthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/11539080-000000000-00000","article-title":"A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions","volume":"12","author":"Winnicki M","year":"2011","unstructured":"Winnicki M, Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. Am J Clin Dermatol. 2011, 12:171-80. 10.2165\/11539080-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.11.028","article-title":"Celecoxib and bullous symmetrical drug-related intertriginous and flexural exanthem (SDRIFE)","volume":"11","author":"Ding R","year":"2023","unstructured":"Ding R, Cheo FF, Lee HY. Celecoxib and bullous symmetrical drug-related intertriginous and flexural exanthem (SDRIFE). J Allergy Clin Immunol Pract. 2023, 11:629-31. 10.1016\/j.jaip.2022.11.028","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14090","article-title":"Symmetric drug-related intertriginous and flexural exanthema: clinicopathologic study of 19 cases and review of literature","volume":"48","author":"Schuler AM","year":"2021","unstructured":"Schuler AM, Smith EH, Chaudet KM, et al.. Symmetric drug-related intertriginous and flexural exanthema: clinicopathologic study of 19 cases and review of literature. J Cutan Pathol. 2021, 48:1471-9. 10.1111\/cup.14090","journal-title":"J Cutan Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5070\/D32ws5h2s0","article-title":"Systemic drug-related intertriginous and flexural exanthema (SDRIFE)","volume":"15","author":"Elmariah SB","year":"2009","unstructured":"Elmariah SB, Cheung W, Wang N, Kamino H, Pomeranz MK. Systemic drug-related intertriginous and flexural exanthema (SDRIFE). Dermatol Online J. 2009, 15:1-4. 10.5070\/D32ws5h2s0","journal-title":"Dermatol Online J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.10.015","article-title":"Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by mefenamic acid","volume":"5","author":"Weiss D","year":"2019","unstructured":"Weiss D, Kinaciyan T. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by mefenamic acid. JAAD Case Rep. 2019, 5:89-90. 10.1016\/j.jdcr.2018.10.015","journal-title":"JAAD Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001722","article-title":"Histopathological spectrum and immunophenotypic characterization of symmetrical drug-related intertriginous and flexural exanthema","volume":"43","author":"Muresan AM","year":"2021","unstructured":"Muresan AM, Metze D, B\u00f6er-Auer A, Braun SA. Histopathological spectrum and immunophenotypic characterization of symmetrical drug-related intertriginous and flexural exanthema. Am J Dermatopathol. 2021, 43:103-11. 10.1097\/DAD.0000000000001722","journal-title":"Am J Dermatopathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz RA","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol. 2013, 69:187.e1-16; quiz 203-4. 10.1016\/j.jaad.2013.05.002","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): a review and update","volume":"73","author":"Szatkowski J","year":"2015","unstructured":"Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol. 2015, 73:843-8. 10.1016\/j.jaad.2015.07.017","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna G","year":"2012","unstructured":"Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous dermatosis. Clin Dermatol. 2012, 30:38-50. 10.1016\/j.clindermatol.2011.03.008","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.05.018","article-title":"Toxic erythema of chemotherapy: a useful clinical term","volume":"59","author":"Bolognia JL","year":"2008","unstructured":"Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol. 2008, 59:524-9. 10.1016\/j.jaad.2008.05.018","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/303414-bullous-symmetric-drug-related-intertriginous-and-flexural-exanthem-secondary-to-trimethoprimsulfamethoxazole","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T04:16:05Z","timestamp":1731039365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/303414-bullous-symmetric-drug-related-intertriginous-and-flexural-exanthem-secondary-to-trimethoprimsulfamethoxazole"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.73248","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,7]]}}}